Background illustration for clinical trials search

Paid Clinical Trials Newark

Discover 1,568 paid clinical trials in Newark, New Jersey. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter

Filter results

Results: 1,568

A Clinical Study of Calderasib (MK-1084) With Targeted Therapy and Chemotherapy in People With Colorectal Cancer (MK-1084-012/KANDLELIT-012)

for

Colon Adenocarcinoma, Rectal Adenocarcinoma

Location: Summit NJ, New York NY, Hackensack NJ, Easton PA,

Sponsor: Merck Sharp & Dohme LLC

Sex: All

Age: 18+

Code: NCT06997497

Phase3, Recruiting

DOC1021 Dendritic Cell Immunotherapy for Treatment of Newly Diagnosed Adult Glioblastoma (GBM)

for

Glioblastoma (GBM)

Location: Summit NJ, New York NY, New Brunswick NJ, Camden NJ,

Sponsor: Diakonos Oncology Corporation

Sex: All

Age: 18+

Code: NCT06805305

Phase2, Recruiting

Trial of Compassionate Use of hp802-247 to Treat Venous Leg Ulcers in Subjects Who Have Failed Multiple Other Healing Technologies

for

Venous Leg Ulcer

Location: Summit NJ

Sponsor: Atlantic Health System

Sex: All

Age: 0+

Code: NCT01320605

Phase2, Recruiting

Letrozole in Uterine Leiomyosarcoma

for

Uterine Leiomyosarcoma

Location: Summit NJ, Morristown NJ, Willow Grove PA,

Sponsor: GOG Foundation

Sex: Female

Age: 18+

Code: NCT05649956

Phase2, Recruiting

Middle Meningeal Artery (MMA) Embolization Compared to Traditional Surgical Strategies to Treat Chronic Subdural Hematomas (cSDH)

for

Chronic Subdural Hematoma

Location: Summit NJ

Sponsor: Atlantic Health System

Sex: All

Age: 18+

Code: NCT04095819

Recruiting

A Multicenter Trial Assessing the Impact of Lipoprotein(a) Lowering With Pelacarsen (TQJ230) on the Progression of Calcific Aortic Valve Stenosis

for

Aortic Stenosis

Location: Summit NJ, New York NY, Philadelphia PA, Albany NY,

Sponsor: Novartis Pharmaceuticals

Sex: All

Age: 50 - 70+

Code: NCT05646381

Phase2, Recruiting

A Study of CPI-613 With Gemcitabine and Nab-paclitaxel for Patients With Advanced or Metastatic Pancreatic Cancer

for

Pancreatic Cancer, Metastatic Pancreatic Cancer

Location: Summit NJ, Morristown NJ

Sponsor: Atlantic Health System

Sex: All

Age: 18+

Code: NCT03435289

Phase1, Recruiting

A Study of Amivantamab in Combination With Lazertinib, or Amivantamab in Combination With Platinum-Based Chemotherapy, for Common Epidermal Growth Factor Receptor (EGFR)-Mutated Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC)

for

Carcinoma, Non-Small-Cell Lung

Location: Summit NJ, New York NY, Morristown NJ, The Bronx NY,

Sponsor: Janssen Research & Development, LLC

Sex: All

Age: 18+

Code: NCT06667076

Phase2, Recruiting

A Study to Evaluate the Effectiveness and Safety of Setidegrasib, Given With Either mFOLFIRINOX or NALIRIFOX Chemotherapies, in People With Pancreatic Cancer

for

Pancreatic Cancer, Metastatic Pancreatic Cancer,

Location: Morristown NJ, New York NY, Basking Ridge NJ,

Sponsor: Astellas Pharma Global Development, Inc.

Sex: All

Age: 18+

Code: NCT07409272

Phase3, Recruiting

IGNITE: Study of Tirabrutinib vs Rituximab/Temozolomide for Relapsed/Refractory Primary Central Nervous System Lymphoma (PCNSL)

for

Relapsed/Refractory Primary Central Nervous System Lymphoma

Location: Summit NJ, New York NY, Hackensack NJ, New Haven CT,

Sponsor: Ono Pharmaceutical Co., Ltd.

Sex: All

Age: 18+

Code: NCT07104032

Phase3, Recruiting

A Study of Tersolisib (LY4064809/STX-478) With Other Anti-Cancer Treatments in Participants With Advanced Breast Cancer With a Genetic Change (PIK3CA)

for

Breast Neoplasms, Neoplasm Metastasis

Location: Summit NJ, Philadelphia PA, Willow Grove PA,

Sponsor: Eli Lilly and Company

Sex: All

Age: 18+

Code: NCT07174336

Phase3, Recruiting

Study to Assess the Efficacy and Safety of Rina-S Compared to Treatment of Investigator's Choice in Participants With Endometrial Cancer

for

Endometrial Cancer, Recurrent or Progressive Endometrial Cancer

Location: Summit NJ, New York NY, Teaneck NJ, Morristown NJ,

Sponsor: Genmab

Sex: Female

Age: 18+

Code: NCT07166094

Phase3, Recruiting

A Study to Learn About the Medicine Ponsegromab in Adults With Cancer of the Pancreas Which Has Spread and Caused Significant Body Weight Loss and Fatigue

for

Cachexia, Metastatic Pancreatic Ductal Adenocarcinoma

Location: Summit NJ, New York NY, Morristown NJ, New Brunswick NJ,

Sponsor: Pfizer

Sex: All

Age: 18+

Code: NCT06989437

Phase2, Phase3, Recruiting

Comparing the Clinical Impact of Pancreatic Cyst Surveillance Programs and Associated Biomarkers

for

Pancreatic Neoplasm

Location: Summit NJ, New York NY, Englewood NJ, Morristown NJ,

Sponsor: ECOG-ACRIN Cancer Research Group

Sex: All

Age: 50 - 70+

Code: NCT04239573

Recruiting

An Open Label Extension (OLE) Study (Following Completion of CTQJ230A12301) to Evaluate Long-term Safety and Tolerability of Pelacarsen (TQJ230)

for

Cardiovascular Disease and Lipoprotein(a)

Location: Summit NJ, New York NY, Ridgewood NJ, Manhasset NY,

Sponsor: Novartis Pharmaceuticals

Sex: All

Age: 18 - 70+

Code: NCT07517263

Phase3, Recruiting

Pelacarsen Roll-over Extension Program

for

Atherosclerotic Cardiovascular Disease

Location: Summit NJ, Richmond Hill NY, New Brunswick NJ,

Sponsor: Novartis Pharmaceuticals

Sex: All

Age: 18 - 70+

Code: NCT06875973

Phase3, Recruiting

A Study to Assess the Efficacy and Safety of FORE8394 in Participants With Cancer Harboring BRAF Alterations

for

Cancer Harboring BRAF Alterations, HGG, LGG, Solid Tumors

Location: Summit NJ, New York NY, Norwalk CT, Philadelphia PA,

Sponsor: Fore Biotherapeutics

Sex: All

Age: 8+

Code: NCT05503797

Phase2, Recruiting

S1501 Dual Observational and Randomized Cohort Study of Patients With Metastatic HER-2+ Breast Cancer at Risk of Cardiac Toxicity

for

Cardiotoxicity, HER2/Neu Positive,

Location: Summit NJ, Teaneck NJ, Morristown NJ, Nyack NY,

Sponsor: SWOG Cancer Research Network

Sex: All

Age: 18+

Code: NCT03418961

Phase3, Recruiting

Study of Sacituzumab Govitecan-hziy and Pembrolizumab Versus Treatment of Physician's Choice in Patients With Triple Negative Breast Cancer Who Have Residual Invasive Disease After Surgery and Neoadjuvant Therapy (ASCENT-05/AFT-65 OptimICE-RD/GBG 119/NSABP B-63)

for

Triple Negative Breast Cancer

Location: Summit NJ, New York NY, New Brunswick NJ,

Sponsor: Gilead Sciences

Sex: All

Age: 18+

Code: NCT05633654

Phase3, Recruiting

Vismodegib, FAK Inhibitor GSK2256098, Capivasertib, and Abemaciclib in Treating Patients With Progressive Meningiomas

for

Intracranial Meningioma, Recurrent Meningioma,

Location: Summit NJ, New York NY, Montvale NJ, Lake Success NY,

Sponsor: Alliance for Clinical Trials in Oncology

Sex: All

Age: 18+

Code: NCT02523014

Phase2, Recruiting

Paid Clinical Trials Newark

Filter results

A Clinical Study of Calderasib (MK-1084) With Targeted Therapy and Chemotherapy in People With Colorectal Cancer (MK-1084-012/KANDLELIT-012)

DOC1021 Dendritic Cell Immunotherapy for Treatment of Newly Diagnosed Adult Glioblastoma (GBM)

Trial of Compassionate Use of hp802-247 to Treat Venous Leg Ulcers in Subjects Who Have Failed Multiple Other Healing Technologies

Letrozole in Uterine Leiomyosarcoma

Middle Meningeal Artery (MMA) Embolization Compared to Traditional Surgical Strategies to Treat Chronic Subdural Hematomas (cSDH)

Interested in new trials?

A Multicenter Trial Assessing the Impact of Lipoprotein(a) Lowering With Pelacarsen (TQJ230) on the Progression of Calcific Aortic Valve Stenosis

A Study of CPI-613 With Gemcitabine and Nab-paclitaxel for Patients With Advanced or Metastatic Pancreatic Cancer

A Study of Amivantamab in Combination With Lazertinib, or Amivantamab in Combination With Platinum-Based Chemotherapy, for Common Epidermal Growth Factor Receptor (EGFR)-Mutated Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC)

A Study to Evaluate the Effectiveness and Safety of Setidegrasib, Given With Either mFOLFIRINOX or NALIRIFOX Chemotherapies, in People With Pancreatic Cancer

IGNITE: Study of Tirabrutinib vs Rituximab/Temozolomide for Relapsed/Refractory Primary Central Nervous System Lymphoma (PCNSL)

A Study of Tersolisib (LY4064809/STX-478) With Other Anti-Cancer Treatments in Participants With Advanced Breast Cancer With a Genetic Change (PIK3CA)

Study to Assess the Efficacy and Safety of Rina-S Compared to Treatment of Investigator's Choice in Participants With Endometrial Cancer

A Study to Learn About the Medicine Ponsegromab in Adults With Cancer of the Pancreas Which Has Spread and Caused Significant Body Weight Loss and Fatigue

Comparing the Clinical Impact of Pancreatic Cyst Surveillance Programs and Associated Biomarkers

An Open Label Extension (OLE) Study (Following Completion of CTQJ230A12301) to Evaluate Long-term Safety and Tolerability of Pelacarsen (TQJ230)

Pelacarsen Roll-over Extension Program

A Study to Assess the Efficacy and Safety of FORE8394 in Participants With Cancer Harboring BRAF Alterations

S1501 Dual Observational and Randomized Cohort Study of Patients With Metastatic HER-2+ Breast Cancer at Risk of Cardiac Toxicity

Study of Sacituzumab Govitecan-hziy and Pembrolizumab Versus Treatment of Physician's Choice in Patients With Triple Negative Breast Cancer Who Have Residual Invasive Disease After Surgery and Neoadjuvant Therapy (ASCENT-05/AFT-65 OptimICE-RD/GBG 119/NSABP B-63)

Vismodegib, FAK Inhibitor GSK2256098, Capivasertib, and Abemaciclib in Treating Patients With Progressive Meningiomas